Coya Therapeutics, Inc. (COYA) Tezkor likvidlik koeffitsiyenti
Coya Therapeutics, Inc. (COYA) regulyator T-hujayralaridan foydalangan holda degenerativ miya patologiyalari uchun ilg'or davolash usullarini ishlab chiqadi, bunda muvaffaqiyat patentlar tozaligi va FDA tasdig'iga bog'liq. GURU.Markets platformasidagi bozor kapitalizatsiyasi tendentsiyasi, qaysiki hozirda 13.44 miqdorida, ushbu jarayonni vizuallashtiradi. Biznes ALS bilan kurashish uchun noyob bioplatformaga tayanadi, ilmiy hamjamiyat orasida innovator sifatidagi benuqson imidj esa brendga ulkan qo'llab-quvvatlashni ta'minlaydi.
%20Tezkor%20likvidlik%20ko%E2%80%98rsatkichi&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_COYA_-_Coya-Therapeutics-Inc._-_Quick-Liquidity-Indicator "Coya (COYA) Tezkor likvidlik: 28.04.2023 - 31.10.2026 davri uchun | 👁️GURU.Markets👁️")
COYA (Coya Therapeutics, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Coya Therapeutics, Inc.|COYA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com|COYA - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati Coya|COYA - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Coya Therapeutics|Tezkor likvidlik koeffitsiyenti coyatherapeutics.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Coya Therapeutics Inc, COYA
Coya Therapeutics, Inc. (COYA) ning fundamental xatarlarini baholash kompaniyaning sekin harakatlanuvchi zaxiralarga tayanmasdan, zudlik bilan bajarilishi lozim bo'lgan majburiyatlarini bajarish qobiliyatini tahlil qilishni talab etadi. Ushbu tezkor koeffitsient likvidlik ko'rsatkichi naqd pul va debitorlik qarzlari yig'indisini o'lchaydi, bu esa yuqori kapital intensivligi va monopol daromadlarga erishish uchun zarur bo'lgan uzoq muddatli siklni hisobga olgan holda, neyrodegenerativ kasalliklar terapiyalarini ishlab chiqishni qo'llab-quvvatlash uchun juda muhimdir.
Coya Therapeutics, Inc. raqobatchilari tahlili
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi axsome.com (AXSM)|Tezkor likvidlik ACADIA Pharmaceuticals Inc. (ACAD)|XENE - Shoshilinch likvidlik|Viking Pharma - Tezkor likvidlik ko‘rsatkichi|Supernus Corp (SUPN) - Shoshilinch likvidlik|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|DNLI - Tezkor likvidlik koeffitsiyenti|HRMY (Harmony Biosciences Holdings, Inc.) - Tezkor likvidlik ko‘rsatkichi|Biohaven Ltd - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi AMLX|TRVI (Trevi Corp) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti PRAX|AVXL (anavex.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CBLL (CeriBell)|Prothena Corp (PRTA) - Shoshilinch likvidlik|ALEC - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti ANNX (Annexon Biosciences Inc.)|OMER: Tezkor likvidlik koeffitsiyenti|neurogene.com (NGNE) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik AC Immune SA|Voyager Therapeutics Inc - Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti NMRA|SCLX - Shoshilinch likvidlik|Tevogen Bio Holdings - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Alpha Cognition Inc ACOG|CGTX: Tezkor likvidlik ko‘rsatkichi|Inhibikase Therapeutics Inc - Oraliq likvidlik koeffitsiyenti|SAVA: Tezkor likvidlik koeffitsiyenti|ASRT - Oraliq qoplama koeffitsiyenti|VTGN (VistaGen Therapeutics, Inc.) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Ovid Rx (OVID)|Tezkor likvidlik Acumen Pharmaceuticals, Inc. (ABOS)|Oraliq qoplama koeffitsiyenti CervoMed, Inc.|Alterity Therapeutics Limited - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti CLNN|PepGen Corp - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Jupiter Neurosciences, Inc. JUNS|Relmada Therapeutics, Inc. (RLMD) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti ANVS|GRCE (Grace Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Firefly Neuro (AIFF)|Tezkor likvidlik ko‘rsatkichi KLTO (Klotho Neurosciences Inc)|Oraliq qoplama koeffitsiyenti neurosense-tx.com|Tezkor likvidlik koeffitsiyenti RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA - Tezkor likvidlik ko‘rsatkichi|NRXS - Tezkor likvidlik|Shoshilinch likvidlik Helius Medical|PASG (passagebio.com) - Tezkor likvidlik ko‘rsatkichi|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|NERV (Minerva Neurosciences, Inc.) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti Athira Pharma Inc|Tezkor likvidlik Addex Therapeutics, Ltd. (ADXN)|alzamend.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CYCN (Cyclerion Therapeutics, Inc.)|Protagenic Therapeutics Inc. (PTIX) - Shoshilinch likvidlik|KTTA: Tezkor likvidlik ko‘rsatkichi|CRGT - Tezkor likvidlik koeffitsiyenti|Avenue Therapeutics, Inc (ATXI) - Tezkor likvidlik|BrainStorm Cell Therapeutics Inc. - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Cara Therapeutics, Inc.|Shoshilinch likvidlik chromocell.com CHRO|Tezkor likvidlik koeffitsiyenti ELYM|Tezkor likvidlik ko‘rsatkichi intracellulartherapies.com ITCI|Tezkor likvidlik Longboard Pharma LBPH|Marinus Pharma (MRNS) - Shoshilinch likvidlik|NKGN: Tezkor likvidlik ko‘rsatkichi|Shoshilinch likvidlik neurobopharma.com|SAGE: Tezkor likvidlik koeffitsiyenti|Synaptogenix Inc. (SNPX) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi TRVN|VIGL: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi WENA (Anew Medical)|Oraliq likvidlik koeffitsiyenti CERE